Ertapenem Resistance of Escherichia coli
Supporting Files
Public Domain
-
Feb 2007
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days. Ertapenem resistance may be explained by a defect in the outer membrane protein and production of extended-spectrum beta-lactamase CTX-M-2.
-
Subjects:
- Dispatch
- Ertapenem Resistance
- Escherichia Coli
- Ctx-M
- Extended-Spectrum Β-Lactamase
- Outer Membrane Protein
- Anti-Bacterial Agents
- Antifungal Agents
- Cilastatin
- Drug Combinations
- Drug Resistance, Multiple, Bacterial
- Escherichia Coli Infections
- Female
- Fluconazole
- Gentamicins
- Humans
- Imipenem
- Immunocompromised Host
- Middle Aged
- Vancomycin
- Beta-Lactams
-
Source:Emerg Infect Dis. 13(2):315-317.
-
Document Type:
-
Volume:13
-
Issue:2
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:60ba1bbec77cbd2c56e482a1056e2561d472147d428745666218f9d25736d866
Supporting Files
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases